» Articles » PMID: 23752516

Epidemiology and Risk Factors for Isolation of Escherichia Coli Producing CTX-M-type Extended-spectrum β-lactamase in a Large U.S. Medical Center

Abstract

A case-case-control study was conducted to identify independent risk factors for recovery of Escherichia coli strains producing CTX-M-type extended-spectrum β-lactamases (CTX-M E. coli) within a large Southeastern Michigan medical center. Unique cases with isolation of ESBL-producing E. coli from February 2010 through July 2011 were analyzed by PCR for blaCTX-M, blaTEM, and blaSHV genes. Patients with CTX-M E. coli were compared to patients with E. coli strains not producing CTX-M-type ESBLs (non-CTX-M E. coli) and uninfected controls. Of 575 patients with ESBL-producing E. coli, 491 (85.4%) isolates contained a CTX-M ESBL gene. A total of 319 (84.6%) patients with CTX-M E. coli (282 [74.8%] CTX-M-15 type) were compared to 58 (15.4%) non-CTX-M E. coli patients and to uninfected controls. Independent risk factors for CTX-M E. coli isolation compared to non-CTX-M E. coli included male gender, impaired consciousness, H2 blocker use, immunosuppression, and exposure to penicillins and/or trimethoprim-sulfamethoxazole. Compared to uninfected controls, independent risk factors for isolation of CTX-M E. coli included presence of a urinary catheter, previous urinary tract infection, exposure to oxyimino-cephalosporins, dependent functional status, non-home residence, and multiple comorbid conditions. Within 48 h of admission, community-acquired CTX-M E. coli (n = 51 [16%]) and non-CTX-M E coli (n = 11 [19%]) strains were isolated from patients with no recent health care contacts. CTX-M E. coli strains were more resistant to multiple antibiotics than non-CTX-M E. coli strains. CTX-M-encoding genes, especially bla(CTX-M-15) type, represented the most common ESBL determinants from ESBL-producing E. coli, the majority of which were present upon admission. Septic patients with risk factors for isolation of CTX-M E. coli should be empirically treated with appropriate agents. Regional infection control efforts and judicious antibiotic use are needed to control the spread of these organisms.

Citing Articles

Effect of methenamine hippurate shortage on antibiotic prescribing for urinary tract infections in Norway-an interrupted time series analysis.

Heltveit-Olsen S, Gopinathan U, Blix H, Elstrom P, Hoye S J Antimicrob Chemother. 2024; 79(5):1109-1117.

PMID: 38635298 PMC: 11062941. DOI: 10.1093/jac/dkae078.


Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections.

Maranchick N, Webber J, Alshaer M, Felton T, Peloquin C Antibiotics (Basel). 2023; 12(12).

PMID: 38136730 PMC: 10740680. DOI: 10.3390/antibiotics12121696.


Risk Factors Associated With Antimicrobial Resistance and Adverse Short-Term Health Outcomes Among Adult and Adolescent Female Outpatients With Uncomplicated Urinary Tract Infection.

Trautner B, Kaye K, Gupta V, Mulgirigama A, Mitrani-Gold F, Scangarella-Oman N Open Forum Infect Dis. 2023; 9(12):ofac623.

PMID: 37065971 PMC: 10101691. DOI: 10.1093/ofid/ofac623.


Methenamine hippurate to prevent recurrent urinary tract infections in older women: protocol for a randomised, placebo-controlled trial (ImpresU).

Heltveit-Olsen S, Sundvall P, Gunnarsson R, Snaebjornsson Arnljots E, Kowalczyk A, Godycki-Cwirko M BMJ Open. 2022; 12(11):e065217.

PMID: 36319057 PMC: 10098264. DOI: 10.1136/bmjopen-2022-065217.


Detection of Clones B2-ST131-C2 and A-ST617 in Producing Both CTX-M-15 and CTX-M-27 from Tunisian Community Patients.

Mhaya A, Trabelsi R, Aillerie S, Mzali F, Begu D, Tounsi S Antibiotics (Basel). 2022; 11(10).

PMID: 36289987 PMC: 9598323. DOI: 10.3390/antibiotics11101329.


References
1.
Rodriguez-Bano J, Picon E, Gijon P, Hernandez J, Ruiz M, Pena C . Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2009; 50(1):40-8. DOI: 10.1086/649537. View

2.
Harris A, Samore M, Lipsitch M, Kaye K, Perencevich E, Carmeli Y . Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis. 2002; 34(12):1558-63. DOI: 10.1086/340533. View

3.
Lewis 2nd J, Herrera M, Wickes B, Patterson J, Jorgensen J . First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother. 2007; 51(11):4015-21. PMC: 2151438. DOI: 10.1128/AAC.00576-07. View

4.
McGettigan S, Hu B, Andreacchio K, Nachamkin I, Edelstein P . Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania. J Clin Microbiol. 2009; 47(9):2970-4. PMC: 2738063. DOI: 10.1128/JCM.00319-09. View

5.
Sidjabat H, Paterson D, Adams-Haduch J, Ewan L, Pasculle A, Muto C . Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009; 53(11):4733-9. PMC: 2772316. DOI: 10.1128/AAC.00533-09. View